These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12437107)

  • 1. Inhibition of mammalian legumain by Michael acceptors and AzaAsn-halomethylketones.
    Niestroj AJ; Feussner K; Heiser U; Dando PM; Barrett A; Gerhartz B; Demuth HU
    Biol Chem; 2002; 383(7-8):1205-14. PubMed ID: 12437107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aza-peptide epoxides: potent and selective inhibitors of Schistosoma mansoni and pig kidney legumains (asparaginyl endopeptidases).
    James KE; Götz MG; Caffrey CR; Hansell E; Carter W; Barrett AJ; McKerrow JH; Powers JC
    Biol Chem; 2003 Dec; 384(12):1613-8. PubMed ID: 14719804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10.
    Ekici OD; Li ZZ; Campbell AJ; James KE; Asgian JL; Mikolajczyk J; Salvesen GS; Ganesan R; Jelakovic S; Grütter MG; Powers JC
    J Med Chem; 2006 Sep; 49(19):5728-49. PubMed ID: 16970398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidyl beta-homo-aspartals (3-amino-4-carboxybutyraldehydes): new specific inhibitors of caspases.
    Bajusz S; Fauszt I; Németh K; Barabás E; Juhász A; Patthy M; Bauer PI
    Biopolymers; 1999; 51(1):109-18. PubMed ID: 10380358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and evaluation of aza-peptide epoxides as selective and potent inhibitors of caspases-1, -3, -6, and -8.
    James KE; Asgian JL; Li ZZ; Ekici OD; Rubin JR; Mikolajczyk J; Salvesen GS; Powers JC
    J Med Chem; 2004 Mar; 47(6):1553-74. PubMed ID: 14998341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorimetric and fluorimetric microplate assays for legumain and a staining reaction for detection of the enzyme after electrophoresis.
    Johansen HT; Knight CG; Barrett AJ
    Anal Biochem; 1999 Sep; 273(2):278-83. PubMed ID: 10469498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies.
    Dragovich PS; Webber SE; Babine RE; Fuhrman SA; Patick AK; Matthews DA; Reich SH; Marakovits JT; Prins TJ; Zhou R; Tikhe J; Littlefield ES; Bleckman TM; Wallace MB; Little TL; Ford CE; Meador JW; Ferre RA; Brown EL; Binford SL; DeLisle DM; Worland ST
    J Med Chem; 1998 Jul; 41(15):2819-34. PubMed ID: 9667971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aza-peptidyl Michael acceptors. A new class of potent and selective inhibitors of asparaginyl endopeptidases (legumains) from evolutionarily diverse pathogens.
    Götz MG; James KE; Hansell E; Dvorák J; Seshaadri A; Sojka D; Kopácek P; McKerrow JH; Caffrey CR; Powers JC
    J Med Chem; 2008 May; 51(9):2816-32. PubMed ID: 18416543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Legumain forms from plants and animals differ in their specificity.
    Rotari VI; Dando PM; Barrett AJ
    Biol Chem; 2001 Jun; 382(6):953-9. PubMed ID: 11501761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pig kidney legumain: an asparaginyl endopeptidase with restricted specificity.
    Dando PM; Fortunato M; Smith L; Knight CG; McKendrick JE; Barrett AJ
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):743-9. PubMed ID: 10215615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two novel asparaginyl endopeptidase-like cysteine proteinases from the protist Trichomonas vaginalis: their evolutionary relationship within the clan CD cysteine proteinases.
    León-Félix J; Ortega-López J; Orozco-Solís R; Arroyo R
    Gene; 2004 Jun; 335():25-35. PubMed ID: 15194187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aza-peptide epoxides: a new class of inhibitors selective for clan CD cysteine proteases.
    Asgian JL; James KE; Li ZZ; Carter W; Barrett AJ; Mikolajczyk J; Salvesen GS; Powers JC
    J Med Chem; 2002 Nov; 45(23):4958-60. PubMed ID: 12408706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aza-peptide Michael acceptors: a new class of inhibitors specific for caspases and other clan CD cysteine proteases.
    Ekici OD; Götz MG; James KE; Li ZZ; Rukamp BJ; Asgian JL; Caffrey CR; Hansell E; Dvorák J; McKerrow JH; Potempa J; Travis J; Mikolajczyk J; Salvesen GS; Powers JC
    J Med Chem; 2004 Apr; 47(8):1889-92. PubMed ID: 15055989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.
    Tavares FX; Boncek V; Deaton DN; Hassell AM; Long ST; Miller AB; Payne AA; Miller LR; Shewchuk LM; Wells-Knecht K; Willard DH; Wright LL; Zhou HQ
    J Med Chem; 2004 Jan; 47(3):588-99. PubMed ID: 14736240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxy terminal extended phytocystatins are bifunctional inhibitors of papain and legumain cysteine proteinases.
    Martinez M; Diaz-Mendoza M; Carrillo L; Diaz I
    FEBS Lett; 2007 Jun; 581(16):2914-8. PubMed ID: 17543305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Cyano-pyrimidines: a new chemotype for inhibitors of the cysteine protease cathepsin K.
    Altmann E; Aichholz R; Betschart C; Buhl T; Green J; Irie O; Teno N; Lattmann R; Tintelnot-Blomley M; Missbach M
    J Med Chem; 2007 Feb; 50(4):591-4. PubMed ID: 17256925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aza-peptidyl Michael acceptor and epoxide inhibitors--potent and selective inhibitors of Schistosoma mansoni and Ixodes ricinus legumains (asparaginyl endopeptidases).
    Ovat A; Muindi F; Fagan C; Brouner M; Hansell E; Dvorák J; Sojka D; Kopácek P; McKerrow JH; Caffrey CR; Powers JC
    J Med Chem; 2009 Nov; 52(22):7192-210. PubMed ID: 19848405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics.
    Dragovich PS; Prins TJ; Zhou R; Johnson TO; Hua Y; Luu HT; Sakata SK; Brown EL; Maldonado FC; Tuntland T; Lee CA; Fuhrman SA; Zalman LS; Patick AK; Matthews DA; Wu EY; Guo M; Borer BC; Nayyar NK; Moran T; Chen L; Rejto PA; Rose PW; Guzman MC; Dovalsantos EZ; Lee S; McGee K; Mohajeri M; Liese A; Tao J; Kosa MB; Liu B; Batugo MR; Gleeson JP; Wu ZP; Liu J; Meador JW; Ferre RA
    J Med Chem; 2003 Oct; 46(21):4572-85. PubMed ID: 14521419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 1.
    Liu H; Tully DC; Epple R; Bursulaya B; Li J; Harris JL; Williams JA; Russo R; Tumanut C; Roberts MJ; Alper PB; He Y; Karanewsky DS
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4979-84. PubMed ID: 16183279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, SAR, and X-ray structure of novel potent DPPIV inhibitors: oxadiazolyl ketones.
    Koo KD; Kim MJ; Kim S; Kim KH; Hong SY; Hur GC; Yim HJ; Kim GT; Han HO; Kwon OH; Kwon TS; Koh JS; Lee CS
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4167-72. PubMed ID: 17544668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.